Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

HPV DNA detection assays for cervical screening

Peter J. F. Snijders, Daniëlle A. M. Heideman, Bart T. Hesselink, Johannes Berkhof, Chris J. L. M. Meijer

. 2008 ; 16 (Suppl.) : S17-S18.
. 2008 ; 16 (Suppl.) : S17-S18.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc11039783

Various high-risk HPV (hr HPV) DNA assays have been developed that allow detection of a broad spectrum of HR HPVs. Two of these assays [Hybrid Capture 2 (hc2) and GP5+/6+-PCR] have shown in large clinical trials a superior clinical sensitivity for cervical (pre)cancer compared to cytology and an optimal balance between clinical sensitivity and pecificity. Comparative studies showed that an increased sensitivity for HR HPV relative to GP5+/6+-PCR and/or hc2 results in a dramatic decrease in clinical specificity, whereas on the other hand a decreased sensitivity for virus leads to a decrease in sensitivity for (pre)cancer. These data argue for guidelines on HR HPV test requirements for cervical screening purposes.

HPV in Human Pathology. Prague, Czech Republic, May 1-3, 2008

Bibliografie atd.

Lit.: 7

000      
00000naa 2200000 a 4500
001      
bmc11039783
003      
CZ-PrNML
005      
20150319090430.0
008      
111111s2008 xr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Snijders, Peter J. F.
245    10
$a HPV DNA detection assays for cervical screening / $c Peter J. F. Snijders, Daniëlle A. M. Heideman, Bart T. Hesselink, Johannes Berkhof, Chris J. L. M. Meijer
314    __
$a Department of Pathology, VU University Medical Center, Amsterdam
500    __
$a HPV in Human Pathology. Prague, Czech Republic, May 1-3, 2008
504    __
$a Lit.: 7
520    9_
$a Various high-risk HPV (hr HPV) DNA assays have been developed that allow detection of a broad spectrum of HR HPVs. Two of these assays [Hybrid Capture 2 (hc2) and GP5+/6+-PCR] have shown in large clinical trials a superior clinical sensitivity for cervical (pre)cancer compared to cytology and an optimal balance between clinical sensitivity and pecificity. Comparative studies showed that an increased sensitivity for HR HPV relative to GP5+/6+-PCR and/or hc2 results in a dramatic decrease in clinical specificity, whereas on the other hand a decreased sensitivity for virus leads to a decrease in sensitivity for (pre)cancer. These data argue for guidelines on HR HPV test requirements for cervical screening purposes.
650    _2
$a infekce papilomavirem $x diagnóza $x imunologie $7 D030361
650    _2
$a nádory děložního čípku $x diagnóza $x etiologie $x imunologie $7 D002583
650    _2
$a prekancerózy $x diagnóza $x etiologie $x imunologie $7 D011230
650    _2
$a dysplazie děložního hrdla $x diagnóza $x etiologie $x imunologie $7 D002578
650    _2
$a diagnostické techniky molekulární $x metody $x využití $7 D025202
650    _2
$a polymerázová řetězová reakce $x metody $x normy $x využití $7 D016133
650    _2
$a hybridizace in situ $x metody $x normy $x využití $7 D017403
650    _2
$a plošný screening $x metody $x normy $x využití $7 D008403
650    _2
$a lidé $7 D006801
700    1_
$a Heideman, Daniëlle A. M.
700    1_
$a Hesselink, Bart T.
700    1_
$a Berkhof, Johannes
700    1_
$a Meijer, Chris J. L. M.
773    0_
$w MED00001083 $t Central European journal of public health $g Roč. 16,Suppl. (2008), s. S17-S18 $x 1210-7778
773    0_
$t Central European journal of public health $g Roč. 16,Suppl. (2008), s. S17-S18 $w MED00001083
856    41
$u https://cejph.szu.cz/pdfs/cjp/2008/88/07.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 1829 $c 562 $y 2 $z 0
990    __
$a 20111109144052 $b ABA008
991    __
$a 20150319090714 $b ABA008
999    __
$a ok $b bmc $g 885961 $s 750166
BAS    __
$a 3
BMC    __
$a 2008 $b 16 $c Suppl. $d S17-S18 $m Central European Journal of Public Health $x MED00001083
BMC    __
$a 2008 $b 16 $c Suppl. $d S17-S18 $m HPV in human pathology $x MED00170653
LZP    __
$a 2011-CEJPH

Najít záznam